Picture of CareDx logo

CDNA — CareDx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

CareDx Inc reports results for the quarter ended in March - Earnings Summary

* CareDx Inc  CDNA.OQ  reported a quarterly adjusted loss
of 11
cents​​ per share for the quarter ended in March. The mean
expectation of seven analysts for the quarter was for a loss
of 11 cents per share.
    * Revenue fell 2.7% to $77.26 million from a year ago;
analysts
expected $80.70 million. 
    * CareDx Inc's reported EPS for the quarter was a loss of 44
cents​.
    * The mean earnings estimate of analysts had fallen by
about 58.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * CareDx Inc shares had fallen by 6.7% this quarter and
lost 25.2%
so far this year.
    * The company reported a quarterly loss of $23.75 million.
    * Wall Street's median 12-month price target for CareDx Inc
is
$16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.11          -0.11          Met
 Dec. 31 2022      -0.09          -0.07          Beat
 Sep. 30 2022      -0.14          -0.06          Beat
 Jun. 30 2022      -0.11          -0.13          Missed

Recent news on CareDx

See all news